Kemnay Advisory Services’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
Kemnay Advisory Services's ANIK Position: Q3 2026 in Review
Kemnay Advisory Services increased its Anika Therapeutics (ANIK) stake by 31% in Q3 2026, buying an estimated $47.7K and bringing the position to 10,450 shares worth $205K. The position accounts for 0.02% of the portfolio, ranked #88.
Kemnay Advisory Services first reported a position in ANIK in Q1 2026 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.
- Kemnay Advisory Services held 10,450 shares of Anika Therapeutics worth $205K as of Q3 2026.
- Kemnay Advisory Services bought 2,492 Anika Therapeutics shares in Q3 2026, an estimated $47.7K.
- Anika Therapeutics made up 0.02% of Kemnay Advisory Services's portfolio in Q3 2026, its #88 holding.
- Kemnay Advisory Services first reported a position in Anika Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 138 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.
Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.